These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 17825579)

  • 1. Soluble HLA-G: Are they clinically relevant?
    Pistoia V; Morandi F; Wang X; Ferrone S
    Semin Cancer Biol; 2007 Dec; 17(6):469-79. PubMed ID: 17825579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release.
    Morandi F; Levreri I; Bocca P; Galleni B; Raffaghello L; Ferrone S; Prigione I; Pistoia V
    Cancer Res; 2007 Jul; 67(13):6433-41. PubMed ID: 17616704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy.
    Rizzo R; Andersen AS; Lassen MR; Sørensen HC; Bergholt T; Larsen MH; Melchiorri L; Stignani M; Baricordi OR; Hviid TV
    Am J Reprod Immunol; 2009 Nov; 62(5):320-38. PubMed ID: 19811467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of blood processing on estimation of soluble HLA-G.
    Poláková K; Bandžuchová E; Russ G
    Neoplasma; 2011; 58(4):337-42. PubMed ID: 21520991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification and identification of soluble HLA-G isoforms.
    Rebmann V; LeMaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
    Tissue Antigens; 2007 Apr; 69 Suppl 1():143-9. PubMed ID: 17445190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms.
    Hviid TV; Rizzo R; Christiansen OB; Melchiorri L; Lindhard A; Baricordi OR
    Immunogenetics; 2004 Jun; 56(3):135-41. PubMed ID: 15133645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage.
    Fainardi E; Rizzo R; Lupato A; Ramponi V; De Santis G; Garofano F; Stignani M; Tamborino C; Castellazzi M; Casetta I; Baricordi OR
    Acta Neurochir Suppl; 2010; 106():141-5. PubMed ID: 19812937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
    Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
    Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of the soluble isoforms of HLA-G.
    Hunt JS; Pace JL; Morales PJ; Ober C
    Mol Hum Reprod; 2003 Nov; 9(11):729-35. PubMed ID: 14561816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretion of sHLA-G molecules in malignancies.
    Rebmann V; Regel J; Stolke D; Grosse-Wilde H
    Semin Cancer Biol; 2003 Oct; 13(5):371-7. PubMed ID: 14708717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease.
    Borghi A; Fogli E; Stignani M; Melchiorri L; Altieri E; Baricordi O; Rizzo R; Virgili A
    Arch Dermatol Res; 2008 Nov; 300(10):551-9. PubMed ID: 18797896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of human leucocyte antigen G in peripheral blood of kidney transplantation recipients].
    Xiao L; Shi BY; Cai M; He XY; Xu XG; Han Y; Zhou WQ; Meng XY; Gao Y
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(4):241-4. PubMed ID: 20356537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.
    Fainardi E; Rizzo R; Melchiorri L; Castellazzi M; Paolino E; Tola MR; Granieri E; Baricordi OR
    Mult Scler; 2006 Feb; 12(1):2-12. PubMed ID: 16459714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-G and lymphoproliferative disorders.
    Amiot L; Le Friec G; Sebti Y; Drénou B; Pangault C; Guilloux V; Leleu X; Bernard M; Facon T; Fauchet R
    Semin Cancer Biol; 2003 Oct; 13(5):379-85. PubMed ID: 14708718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004.
    Rebmann V; Lemaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
    Hum Immunol; 2005 Aug; 66(8):853-63. PubMed ID: 16216668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy.
    Alegre E; Díaz-Lagares A; Lemaoult J; López-Moratalla N; Carosella ED; González A
    Hum Immunol; 2007 Aug; 68(8):661-7. PubMed ID: 17678720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histocompatibility HLA system of man. Considerations in the light of current concepts. V. sHLA-I in patient's body fluids].
    Kedzierska A; Turowski G
    Przegl Lek; 2001; 58(9):868-72. PubMed ID: 11868250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble HLA-G molecules are increased in lymphoproliferative disorders.
    Sebti Y; Le Friec G; Pangault C; Gros F; Drénou B; Guilloux V; Bernard M; Lamy T; Fauchet R; Amiot L
    Hum Immunol; 2003 Nov; 64(11):1093-101. PubMed ID: 14602240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
    Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
    Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.
    Le Rond S; Gonzalez A; Gonzalez AS; Carosella ED; Rouas-Freiss N
    Immunology; 2005 Nov; 116(3):297-307. PubMed ID: 16236119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.